Logo image of BHV

BLACKROCK VIRGINIA MUNI BND (BHV) Stock Price, Quote, News and Overview

NYSE:BHV - New York Stock Exchange, Inc. - US0924811005 - Currency: USD

10.445  +0.03 (+0.24%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to BHV. BHV was compared to 0 industry peers in the Unkown industry. BHV has a bad profitability rating. Also its financial health evaluation is rather negative. BHV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

BHV had negative earnings in the past year.
In the past year BHV had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BHV reported negative net income in multiple years.
BHV had a positive operating cash flow in each of the past 5 years.
BHV Yearly Net Income VS EBIT VS OCF VS FCFBHV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M 2M 3M 4M

1.2 Ratios

Industry RankSector Rank
ROA -2.34%
ROE -4.06%
ROIC 1.32%
ROA(3y)0.74%
ROA(5y)1.44%
ROE(3y)1.16%
ROE(5y)2.38%
ROIC(3y)1.56%
ROIC(5y)1.7%
BHV Yearly ROA, ROE, ROICBHV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15

1.3 Margins

In the last couple of years the Operating Margin of BHV has declined.
BHV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 40%
PM (TTM) N/A
GM 42.86%
OM growth 3Y-10.09%
OM growth 5Y-10.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.14%
GM growth 5Y-8.65%
BHV Yearly Profit, Operating, Gross MarginsBHV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 200

More info and screens

1

2. Health

2.1 Basic Checks

BHV has less shares outstanding than it did 1 year ago.
BHV has about the same amout of shares outstanding than it did 5 years ago.
BHV has about the same debt/assets ratio as last year.
BHV Yearly Shares OutstandingBHV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
BHV Yearly Total Debt VS Total AssetsBHV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of 0.62, we must say that BHV is in the distress zone and has some risk of bankruptcy.
The Debt to FCF ratio of BHV is 7.88, which is on the high side as it means it would take BHV, 7.88 years of fcf income to pay off all of its debts.
BHV has a Debt/Equity ratio of 0.68. This is a neutral value indicating BHV is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.88
Altman-Z 0.62
ROIC/WACCN/A
WACCN/A
BHV Yearly LT Debt VS Equity VS FCFBHV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.3 Liquidity

A Current Ratio of 0.01 indicates that BHV may have some problems paying its short term obligations.
BHV has a Quick Ratio of 0.01. This is a bad value and indicates that BHV is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
BHV Yearly Current Assets VS Current LiabilitesBHV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

BHV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -118.11%.
BHV shows a small growth in Revenue. In the last year, the Revenue has grown by 3.94%.
Measured over the past years, BHV shows a decrease in Revenue. The Revenue has been decreasing by -5.01% on average per year.
EPS 1Y (TTM)-118.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%196%
Revenue 1Y (TTM)3.94%
Revenue growth 3Y-6.08%
Revenue growth 5Y-5.01%
Sales Q2Q%1.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BHV Yearly Revenue VS EstimatesBHV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BHV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHV Price Earnings VS Forward Price EarningsBHV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 9.66
EV/EBITDA N/A
BHV Per share dataBHV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.29%, BHV is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.34, BHV pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.29%

5.2 History

The dividend of BHV decreases each year by -10.53%.
BHV has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BHV decreased recently.
Dividend Growth(5Y)-10.53%
Div Incr Years1
Div Non Decr Years1
BHV Yearly Dividends per shareBHV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of BHV are negative and hence is the payout ratio. BHV will probably not be able to sustain this dividend level.
DP-85.19%
EPS Next 2YN/A
EPS Next 3YN/A
BHV Yearly Income VS Free CF VS DividendBHV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M 2M 3M 4M

More info and screens

BLACKROCK VIRGINIA MUNI BND

NYSE:BHV (7/31/2025, 8:06:04 PM)

10.445

+0.03 (+0.24%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.7%
Inst Owner Change-3.09%
Ins OwnersN/A
Ins Owner Change0%
Market Cap16.61M
Analysts0
Price TargetN/A
Short Float %0.66%
Short Ratio2.84
Dividend
Industry RankSector Rank
Dividend Yield 5.29%
Yearly Dividend0.43
Dividend Growth(5Y)-10.53%
DP-85.19%
Div Incr Years1
Div Non Decr Years1
Ex-Date07-15 2025-07-15 (0.0515)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.86
P/FCF 9.66
P/OCF 9.66
P/B 0.83
P/tB 0.83
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.08
FCFY10.36%
OCF(TTM)1.08
OCFY10.36%
SpS0.88
BVpS12.55
TBVpS12.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.34%
ROE -4.06%
ROCE 1.67%
ROIC 1.32%
ROICexc 1.32%
ROICexgc 1.32%
OM 40%
PM (TTM) N/A
GM 42.86%
FCFM 122.86%
ROA(3y)0.74%
ROA(5y)1.44%
ROE(3y)1.16%
ROE(5y)2.38%
ROIC(3y)1.56%
ROIC(5y)1.7%
ROICexc(3y)1.56%
ROICexc(5y)1.7%
ROICexgc(3y)1.56%
ROICexgc(5y)1.7%
ROCE(3y)1.97%
ROCE(5y)2.15%
ROICexcg growth 3Y-8.95%
ROICexcg growth 5Y-11.18%
ROICexc growth 3Y-8.93%
ROICexc growth 5Y-11.17%
OM growth 3Y-10.09%
OM growth 5Y-10.35%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.14%
GM growth 5Y-8.65%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.88
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.14
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 0.62
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%196%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.94%
Revenue growth 3Y-6.08%
Revenue growth 5Y-5.01%
Sales Q2Q%1.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-32.53%
EBIT growth 3Y-15.56%
EBIT growth 5Y-14.84%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y97.7%
FCF growth 3Y18.64%
FCF growth 5Y35.98%
OCF growth 1Y97.7%
OCF growth 3Y18.64%
OCF growth 5Y35.98%